Hankook Tire & Technology Chairman Cho Hyun-bum Appeals Three-Year Prison Sentence in Embezzlement and Breach of Trust Case

Reporter Paul Lee / approved : 2025-08-12 03:32:57
  • -
  • +
  • 인쇄

Cho Hyun-bum, Chairman of Hankook Tire & Technology (Photo = Yonhap News)

 

 

[Alpha Biz= Paul Lee] SEOUL, South Korea – The appellate trial of Cho Hyun-bum (53), Chairman of Hankook Tire & Technology Co., Ltd., has commenced following his conviction in the first trial for embezzlement and breach of trust totaling more than KRW 20 billion. In May, Cho was sentenced to three years in prison and was taken into custody immediately after the ruling.



On August 11, the Seoul High Court’s Criminal Division 13, presided over by Judge Baek Kang-jin, held the first preparatory hearing for Cho, who appeared in court wearing a beige prison uniform. Cho’s legal team argued that the lower court had “misinterpreted evidence” and made “speculative judgments on matters insufficiently examined,” which form the basis of their appeal.



The defense plans to present its case over three separate hearings, focusing on allegations that Cho:



Illegally supported MKT, a Hankook affiliate, by purchasing tire molds at inflated prices between 2014 and 2017,



Lent KRW 5 billion from MKT to Hyundai Motor supplier Rihan without proper collateral,



Used KRW 755 million in company funds for personal expenses, including furniture purchases for his residence.



The first trial found Cho guilty of partially breaching trust in the MKT mold purchase case (six months) and of other embezzlement and breach of trust charges (two years and six months), resulting in a combined three-year sentence.



The appellate court indicated it aims to conclude proceedings before Cho’s detention period ends in late January 2026, avoiding the need for bail or release during the trial. The court will proceed with presentations, witness examinations, and evidence reviews in the coming months.

 

 

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

어플

주요기사

Goldman Sachs Reinitiates Coverage on K-Beauty; Names APR as Top Pick2025.12.11
KRX Designates SK hynix as “Investment Warning” Stock2025.12.11
FSC Orders Budget Recovery and Disciplinary Measures Over Alleged Leisure Activities During Overseas Business Trip2025.12.11
Coupang Replaces Korea CEO Ahead of Parliamentary Hearing as Data Breach Crisis Deepens2025.12.11
U.S. Court Denies Pedal Point Holdings’ Motion to Stay Proceedings Pending Appeal2025.12.11
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사